A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer
Clinical trial NCT02301988 · COMPLETED
Trial details
- NCT number
- NCT02301988
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-17
- Primary completion
- 2017-08-02
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.